Biotech Industry Leaders Join Deep Genomics Board of Directors and Scientific Advisory Board
– Additions expand biotech and oligonucleotide expertise –
TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, today announced additions to its Board of Directors and Scientific Advisory Board which will advance its capabilities to develop oligonucleotides designed to boost protein production across ...